Journal of Pharmaceutical Innovation, Journal Year: 2025, Volume and Issue: 20(2)
Published: March 6, 2025
Language: Английский
Journal of Pharmaceutical Innovation, Journal Year: 2025, Volume and Issue: 20(2)
Published: March 6, 2025
Language: Английский
International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 143012 - 143012
Published: April 1, 2025
Language: Английский
Citations
0European Journal of Medicinal Chemistry Reports, Journal Year: 2025, Volume and Issue: unknown, P. 100268 - 100268
Published: April 1, 2025
Language: Английский
Citations
0Published: Jan. 1, 2025
Language: Английский
Citations
0MEDICINUS, Journal Year: 2025, Volume and Issue: 38(1), P. 27 - 36
Published: Jan. 1, 2025
Proses penemuan obat telah memasuki era baru dengan munculnya kecerdasan buatan (artificial intelligence/AI) dan big data. Pendekatan tradisional, panjang, mahal kini dilengkapi alternatif yang efisien berkat kemampuan AI untuk menganalisis pola kompleks data mengintegrasikan kumpulan berskala besar. Artikel ini membahas peran teknologi tersebut dalam mempercepat inovasi farmasi, mengulas aplikasi praktis, menyoroti tantangan serta prospek masa depan. Dengan data, industri farmasi dapat memajukan pengobatan presisi memperdalam pemahaman kita tentang biologi penyakit.
Citations
0Journal of Pharmaceutical and Biological Sciences, Journal Year: 2025, Volume and Issue: 12(2), P. 109 - 118
Published: Jan. 9, 2025
Because of their diverse clinical manifestations and intricate pathophysiology, autoimmune diseases which are defined by the immune system wrongly attacking healthy tissues present serious difficulties. Artificial intelligence (AI) has shown revolutionary promise in this field, especially improving diagnostic precision, facilitating tailored treatment plans, offering real-time illness tracking. This paper highlights AI's role assessing various datasets pertaining to function pathology while critically examining applications AI therapy diseases. In order find new biomarkers enable early accurate detection disorders, advanced approaches such as machine learning deep have proven essential. AI-powered predictive models demonstrated predicting periods remission disease flares, allowing for prompt focused modifications. Furthermore, accelerating identification promising therapeutic candidates lowering related costs, is transforming drug discovery repurposing. However, issues including data heterogeneity, algorithmic transparency, patient confidence AI-driven suggestions limit full potential need ethical frameworks interdisciplinary collaboration these limits suggesting solutions. shows transform diagnosis, treatment, management disorders combining recent developments future applications. will pave way a where healthcare solutions proactive, accurate, individualized.
Language: Английский
Citations
0Bioprinting, Journal Year: 2025, Volume and Issue: unknown, P. e00394 - e00394
Published: Jan. 1, 2025
Language: Английский
Citations
0Intelligent Pharmacy, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Language: Английский
Citations
0Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(2), P. 188 - 188
Published: Feb. 2, 2025
Transdermal drug delivery systems (TDDS) offer an alternative to conventional oral and injectable administration by bypassing the gastrointestinal tract liver metabolism, improving bioavailability, minimizing systemic side effects. However, widespread adoption of TDDS is limited challenges such as skin’s permeability barrier, particularly stratum corneum, need for optimized formulations. Factors like skin type, hydration levels, age further complicate development universally effective solutions. Advances in artificial intelligence (AI) address these through predictive modeling personalized medicine approaches. Machine learning models trained on extensive molecular datasets predict accelerate selection suitable candidates. AI-driven algorithms optimize formulations, including penetration enhancers advanced technologies microneedles liposomes, while ensuring safety efficacy. Personalized design tailors individual patient profiles, enhancing therapeutic precision. Innovative systems, sensor-integrated patches, dynamically adjust release based real-time feedback, optimal outcomes. AI also streamlines pharmaceutical process, from disease diagnosis prediction distribution layers, enabling efficient formulation development. This review highlights AI’s transformative role TDDS, applications Deep Neural Networks (DNN), Artificial (ANN), BioSIM, COMSOL, K-Nearest Neighbors (KNN), Set Covering (SVM). These revolutionize both non-skin diseases, demonstrating potential overcome existing barriers improve care innovative
Language: Английский
Citations
0Nanomedicine, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 3
Published: Feb. 5, 2025
Language: Английский
Citations
0Phytomedicine, Journal Year: 2025, Volume and Issue: 139, P. 156518 - 156518
Published: Feb. 14, 2025
Language: Английский
Citations
0